CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE was reported 316 times

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE MACULE 1 0.0667
1 COLPOSCOPY ABNORMAL 1 0.0455
2 RECTOCELE REPAIR 1 0.0169
3 PHLEBITIS DEEP 1 0.0135
4 ALLERGY TO ARTHROPOD STING 3 0.0066
5 PAIN MANAGEMENT 1 0.0059
6 HYDROMETRA 1 0.0054
7 HERPES SIMPLEX TEST POSITIVE 1 0.0050
8 APPLICATION SITE HYPOAESTHESIA 1 0.0043
9 TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME 1 0.0040
10 KERATOMILEUSIS 1 0.0039
11 VICTIM OF ABUSE 1 0.0037
12 ASTHMA EXERCISE INDUCED 1 0.0029
13 ENDOMETRIAL ABLATION 1 0.0028
14 KERATOCONUS 1 0.0027
15 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
16 VIRAL PHARYNGITIS 1 0.0025
17 REFLUX LARYNGITIS 1 0.0023
18 MECHANICAL URTICARIA 1 0.0021
19 SLEEP ATTACKS 1 0.0021
20 ECZEMA EYELIDS 1 0.0018
21 URINARY TRACT INFECTION FUNGAL 1 0.0017
22 ALLERGY TO METALS 1 0.0016
23 BORDERLINE PERSONALITY DISORDER 1 0.0014
24 PARASOMNIA 1 0.0014
25 OPTIC NERVE DISORDER 2 0.0012
26 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
27 PHARYNGEAL HYPOAESTHESIA 1 0.0011
28 SLEEP-RELATED EATING DISORDER 1 0.0011
29 METABOLIC SURGERY 1 0.0009
30 RENAL ATROPHY 1 0.0008
31 BENIGN INTRACRANIAL HYPERTENSION 1 0.0008
32 OVARIAN CYST RUPTURED 1 0.0008
33 APPLICATION SITE PARAESTHESIA 1 0.0008
34 RENAL ARTERY STENOSIS 1 0.0007
35 APPLICATION SITE INFLAMMATION 1 0.0007
36 SMEAR CERVIX ABNORMAL 1 0.0007
37 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
38 NECK INJURY 2 0.0007
39 GENERALISED ANXIETY DISORDER 1 0.0007
40 ACNE CYSTIC 2 0.0007
41 PRODUCT DEPOSIT 1 0.0006
42 INAPPROPRIATE AFFECT 1 0.0006
43 OROPHARYNGEAL BLISTERING 1 0.0006
44 EXPOSURE DURING BREAST FEEDING 2 0.0006
45 APPLICATION SITE SWELLING 3 0.0006
46 MITRAL VALVE PROLAPSE 1 0.0006
47 APPLICATION SITE DRYNESS 2 0.0006
48 VERTIGO POSITIONAL 1 0.0006
49 APPLICATION SITE EXFOLIATION 2 0.0005
50 EXPIRED PRODUCT ADMINISTERED 16 0.0005
51 MELANOCYTIC NAEVUS 2 0.0005
52 CORNEAL DISORDER 1 0.0005
53 APPLICATION SITE PAIN 10 0.0005
54 TONGUE BLISTERING 1 0.0004
55 INFECTIOUS MONONUCLEOSIS 1 0.0004
56 PAPILLOEDEMA 2 0.0004
57 EYELID DISORDER 1 0.0004
58 SKIN TIGHTNESS 2 0.0004
59 DERMAL CYST 1 0.0004
60 ANGLE CLOSURE GLAUCOMA 1 0.0004
61 APPLICATION SITE ERYTHEMA 10 0.0004
62 EXFOLIATIVE RASH 1 0.0004
63 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
64 ALCOHOL ABUSE 1 0.0004
65 SKIN DISCOMFORT 1 0.0004
66 THORACIC VERTEBRAL FRACTURE 1 0.0003
67 REBOUND ACID HYPERSECRETION 1 0.0003
68 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
69 ACNE 25 0.0003
70 PIGMENTATION DISORDER 2 0.0003
71 PRE-EXISTING CONDITION IMPROVED 2 0.0003
72 HANGOVER 1 0.0003
73 SKIN DISCOLOURATION 13 0.0003
74 FACIAL PARESIS 1 0.0003
75 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
76 MAJOR DEPRESSION 2 0.0003
77 TENDON INJURY 1 0.0003
78 SNORING 1 0.0003
79 BOWEL MOVEMENT IRREGULARITY 2 0.0003
80 PANIC DISORDER 1 0.0003
81 EPIGASTRIC DISCOMFORT 1 0.0003
82 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
83 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
84 ENURESIS 1 0.0002
85 APPLICATION SITE DISCOLOURATION 1 0.0002
86 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
87 ANAPHYLACTOID REACTION 1 0.0002
88 EYE SWELLING 9 0.0002
89 APPLICATION SITE IRRITATION 3 0.0002
90 SLEEP TERROR 1 0.0002
91 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
92 POOR PERIPHERAL CIRCULATION 1 0.0002
93 PRODUCT DISPENSING ISSUE 1 0.0002
94 ABNORMAL SENSATION IN EYE 1 0.0002
95 APPLICATION SITE PRURITUS 5 0.0002
96 EAR DISORDER 1 0.0002
97 EYE OPERATION 1 0.0002
98 TIBIA FRACTURE 1 0.0002
99 GUILLAIN-BARRE SYNDROME 1 0.0002
100 EXPIRED DRUG ADMINISTERED 1 0.0002
101 HYPERNATRAEMIA 1 0.0002
102 OVARIAN CYST 2 0.0002
103 DRUG TOLERANCE 1 0.0002
104 PRODUCT COLOUR ISSUE 1 0.0002
105 POLYARTHRITIS 1 0.0002
106 CHEILITIS 1 0.0002
107 BACK INJURY 2 0.0002
108 HYDROCEPHALUS 1 0.0002
109 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
110 PERIORBITAL SWELLING 1 0.0002
111 DERMATITIS CONTACT 2 0.0002
112 SWELLING FACE 11 0.0002
113 RESTLESS LEGS SYNDROME 3 0.0002
114 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
115 FOREIGN BODY SENSATION IN EYES 1 0.0002
116 BURNING SENSATION 11 0.0002
117 ANGINA UNSTABLE 1 0.0002
118 TENDON DISORDER 1 0.0002
119 SOMNAMBULISM 1 0.0002
120 POSTOPERATIVE WOUND INFECTION 1 0.0001
121 ECCHYMOSIS 1 0.0001
122 PERIPHERAL COLDNESS 2 0.0001
123 APPLICATION SITE RASH 2 0.0001
124 DROOLING 1 0.0001
125 APPLICATION SITE REACTION 1 0.0001
126 SEASONAL ALLERGY 2 0.0001
127 RASH PUSTULAR 1 0.0001
128 UTERINE LEIOMYOMA 1 0.0001
129 SENSITIVE SKIN 1 0.0001
130 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
131 DRY SKIN 18 0.0001
132 GENERAL SYMPTOM 1 0.0001
133 COLITIS 5 0.0001
134 PRODUCT AVAILABILITY ISSUE 3 0.0001
135 SKIN IRRITATION 6 0.0001
136 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
137 FOOD ALLERGY 1 0.0001
138 CONCUSSION 1 0.0001
139 ERYTHEMA 26 0.0001
140 FURUNCLE 1 0.0001
141 BLOOD DISORDER 1 0.0001
142 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
143 ACUTE CORONARY SYNDROME 1 0.0001
144 SKIN HYPERPIGMENTATION 1 0.0001
145 MUSCULOSKELETAL DISCOMFORT 2 0.0001
146 HYSTERECTOMY 1 0.0001
147 SKIN SWELLING 1 0.0001
148 GALLBLADDER DISORDER 2 0.0001
149 FACIAL PAIN 1 0.0001
150 SKIN BURNING SENSATION 8 0.0001
151 HIDRADENITIS 1 0.0001
152 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
153 APPENDICITIS 1 0.0001
154 ORAL HERPES 2 0.0001
155 VITREOUS FLOATERS 1 0.0001
156 LIGAMENT SPRAIN 1 0.0001
157 DRY THROAT 1 0.0001
158 INITIAL INSOMNIA 1 0.0001
159 BODY HEIGHT DECREASED 1 0.0001
160 BIPOLAR DISORDER 1 0.0001
161 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
162 MITRAL VALVE INCOMPETENCE 1 0.0001
163 CHOLECYSTECTOMY 1 0.0001
164 SUICIDAL IDEATION 8 0.0001
165 SEXUAL DYSFUNCTION 1 0.0001
166 RASH ERYTHEMATOUS 4 0.0001
167 SKIN EXFOLIATION 7 0.0001
168 INJECTION SITE URTICARIA 2 0.0001
169 PHARYNGITIS 1 0.0001
170 HAIR COLOUR CHANGES 1 0.0001
171 INJECTION SITE DISCOLOURATION 1 0.0001
172 MYDRIASIS 1 0.0001
173 INCORRECT PRODUCT STORAGE 1 0.0001
174 BEDRIDDEN 1 0.0001
175 DERMATITIS ATOPIC 4 0.0001
176 SARS-COV-2 TEST POSITIVE 1 0.0001
177 JOINT RANGE OF MOTION DECREASED 1 0.0001
178 PRODUCT QUALITY ISSUE 10 0.0001
179 IMPAIRED GASTRIC EMPTYING 1 0.0001
180 BRONCHOSPASM 1 0.0001
181 GASTROENTERITIS 1 0.0001
182 HYPOAESTHESIA ORAL 1 0.0001
183 LACRIMATION INCREASED 2 0.0001
184 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
185 OSTEOPENIA 1 0.0001
186 NEPHROLITHIASIS 3 0.0001
187 PRURITUS 25 0.0001
188 PHARYNGEAL OEDEMA 1 0.0001
189 TENDONITIS 1 0.0001
190 EXPOSURE DURING PREGNANCY 4 0.0001
191 SWOLLEN TONGUE 2 0.0001
192 MIGRAINE 6 0.0001
193 PREMATURE DELIVERY 1 0.0001
194 BACK DISORDER 1 0.0001
195 MULTIPLE FRACTURES 1 0.0001
196 VISUAL ACUITY REDUCED 2 0.0001
197 FACE OEDEMA 1 0.0001
198 SCAR 1 0.0001
199 ECZEMA 3 0.0001
200 LOCAL SWELLING 1 0.0001
201 HYPOXIA 2 0.0001
202 THERAPY INTERRUPTED 4 0.0001
203 TREATMENT NONCOMPLIANCE 3 0.0001
204 END STAGE RENAL DISEASE 1 0.0001
205 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
206 BRONCHITIS 4 0.0001
207 CONJUNCTIVITIS 1 0.0001
208 HEPATIC STEATOSIS 1 0.0001
209 THINKING ABNORMAL 1 0.0001
210 SWELLING 5 0.0001
211 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
212 GASTRIC ULCER 1 0.0001
213 SLEEP APNOEA SYNDROME 1 0.0001
214 BLOOD PRESSURE INCREASED 8 0.0001
215 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
216 PRESCRIBED OVERDOSE 1 0.0001
217 SKIN FISSURES 1 0.0001
218 KIDNEY INFECTION 1 0.0001
219 MENORRHAGIA 1 0.0001
220 RASH 22 0.0001
221 BLOOD PRESSURE ABNORMAL 1 0.0001
222 IRRITABILITY 3 0.0000
223 NO ADVERSE EVENT 9 0.0000
224 EXTRA DOSE ADMINISTERED 2 0.0000
225 HYPERSENSITIVITY 9 0.0000
226 ROAD TRAFFIC ACCIDENT 2 0.0000
227 DERMATITIS 1 0.0000
228 RETCHING 1 0.0000
229 IRRITABLE BOWEL SYNDROME 1 0.0000
230 POOR QUALITY SLEEP 1 0.0000
231 PRODUCT PRESCRIBING ISSUE 1 0.0000
232 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
233 THROAT IRRITATION 2 0.0000
234 PRODUCT PRESCRIBING ERROR 1 0.0000
235 BLOOD PRESSURE FLUCTUATION 1 0.0000
236 AGEUSIA 1 0.0000
237 DRY EYE 2 0.0000
238 DEPRESSION 9 0.0000
239 HYPOPHAGIA 1 0.0000
240 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
241 INFLAMMATION 2 0.0000
242 ABDOMINAL DISTENSION 4 0.0000
243 SEDATION 1 0.0000
244 ANHEDONIA 1 0.0000
245 GASTRITIS 1 0.0000
246 DISTURBANCE IN ATTENTION 2 0.0000
247 FREQUENT BOWEL MOVEMENTS 1 0.0000
248 RASH PRURITIC 2 0.0000
249 PALLOR 1 0.0000
250 MOOD ALTERED 1 0.0000
251 SKIN LESION 1 0.0000
252 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
253 HAEMATOCHEZIA 2 0.0000
254 DIVERTICULITIS 1 0.0000
255 URTICARIA 6 0.0000
256 BLISTER 2 0.0000
257 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
258 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
259 INTENTIONAL DOSE OMISSION 1 0.0000
260 PRODUCT SUBSTITUTION ISSUE 2 0.0000
261 DYSSTASIA 1 0.0000
262 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
263 SURGERY 2 0.0000
264 PSYCHOTIC DISORDER 1 0.0000
265 URINARY INCONTINENCE 1 0.0000
266 RENAL INJURY 1 0.0000
267 RESPIRATORY DISORDER 1 0.0000
268 CONDITION AGGRAVATED 10 0.0000
269 DISCOMFORT 2 0.0000
270 DRUG ADMINISTRATION ERROR 1 0.0000
271 EMOTIONAL DISORDER 1 0.0000
272 LIMB DISCOMFORT 1 0.0000
273 BONE DENSITY DECREASED 1 0.0000
274 PARAESTHESIA 5 0.0000
275 HEAD INJURY 1 0.0000
276 CYSTITIS 1 0.0000
277 MOOD SWINGS 1 0.0000
278 CHOLELITHIASIS 1 0.0000
279 EYE DISORDER 1 0.0000
280 LIP SWELLING 1 0.0000
281 DEHYDRATION 4 0.0000
282 URINARY RETENTION 1 0.0000
283 ANGER 1 0.0000
284 INJECTION SITE REACTION 2 0.0000
285 RASH MACULAR 1 0.0000
286 LYMPHADENOPATHY 1 0.0000
287 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
288 PRODUCT ADHESION ISSUE 1 0.0000
289 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
290 PANIC ATTACK 1 0.0000
291 RESTLESSNESS 1 0.0000
292 PRODUCT USE ISSUE 5 0.0000
293 DRUG INEFFECTIVE 35 0.0000
294 PERIPHERAL SWELLING 4 0.0000
295 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
296 ABORTION SPONTANEOUS 1 0.0000
297 PSORIATIC ARTHROPATHY 1 0.0000
298 OSTEOPOROSIS 1 0.0000
299 DIZZINESS 12 0.0000
300 WITHDRAWAL SYNDROME 1 0.0000
301 MENTAL DISORDER 1 0.0000
302 MUSCULOSKELETAL STIFFNESS 2 0.0000
303 DRUG WITHDRAWAL SYNDROME 2 0.0000
304 COLITIS ULCERATIVE 1 0.0000
305 GASTROINTESTINAL DISORDER 2 0.0000
306 VISION BLURRED 3 0.0000
307 OROPHARYNGEAL PAIN 2 0.0000
308 ABDOMINAL PAIN 5 0.0000
309 BLOOD CHOLESTEROL INCREASED 1 0.0000
310 ANXIETY 6 0.0000
311 OCULAR HYPERAEMIA 1 0.0000
312 PRODUCTIVE COUGH 1 0.0000
313 BLOOD GLUCOSE DECREASED 1 0.0000
314 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
315 ALOPECIA 4 0.0000
316 DYSPEPSIA 2 0.0000
317 SOMNOLENCE 4 0.0000
318 FLUID RETENTION 1 0.0000
319 SINUSITIS 2 0.0000
320 ILLNESS 2 0.0000
321 MUSCULOSKELETAL PAIN 1 0.0000
322 DEPRESSED MOOD 1 0.0000
323 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
324 DRUG EFFECT DECREASED 1 0.0000
325 ANAPHYLACTIC REACTION 1 0.0000
326 WEIGHT DECREASED 5 0.0000
327 PAIN 11 0.0000
328 NECK PAIN 1 0.0000
329 URINARY TRACT INFECTION 3 0.0000
330 HERPES ZOSTER 1 0.0000
331 SEIZURE 2 0.0000
332 PALPITATIONS 2 0.0000
333 DIARRHOEA 11 0.0000
334 NASAL CONGESTION 1 0.0000
335 WHEEZING 1 0.0000
336 FEELING ABNORMAL 4 0.0000
337 THERAPEUTIC RESPONSE DECREASED 1 0.0000
338 SUICIDE ATTEMPT 1 0.0000
339 STOMATITIS 1 0.0000
340 VERTIGO 1 0.0000
341 MUSCLE SPASMS 3 0.0000
342 FEELING HOT 1 0.0000
343 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
344 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
345 VISUAL IMPAIRMENT 2 0.0000
346 LOSS OF CONSCIOUSNESS 2 0.0000
347 DEVICE EXPULSION 1 0.0000
348 DEEP VEIN THROMBOSIS 1 0.0000
349 AMNESIA 1 0.0000
350 PSORIASIS 2 0.0000
351 NAUSEA 12 0.0000
352 INJECTION SITE PRURITUS 1 0.0000
353 HEPATIC ENZYME INCREASED 1 0.0000
354 MEMORY IMPAIRMENT 2 0.0000
355 SLEEP DISORDER 1 0.0000
356 MOBILITY DECREASED 1 0.0000
357 PAIN IN EXTREMITY 4 0.0000
358 HOT FLUSH 1 0.0000
359 UNEVALUABLE EVENT 1 0.0000
360 CHRONIC KIDNEY DISEASE 1 0.0000
361 DIABETES MELLITUS 1 0.0000
362 INJECTION SITE PAIN 4 0.0000
363 BACK PAIN 3 0.0000
364 DRUG INTERACTION 2 0.0000
365 OFF LABEL USE 11 0.0000
366 INJECTION SITE BRUISING 1 0.0000
367 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
368 DRY MOUTH 1 0.0000
369 DRUG DOSE OMISSION 2 0.0000
370 COMPLETED SUICIDE 1 0.0000
371 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
372 RENAL IMPAIRMENT 1 0.0000
373 PRODUCT STORAGE ERROR 1 0.0000
374 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
375 ADVERSE DRUG REACTION 1 0.0000
376 NASOPHARYNGITIS 2 0.0000
377 CONTUSION 1 0.0000
378 DRUG INTOLERANCE 1 0.0000
379 HYPOTENSION 2 0.0000
380 CHEST DISCOMFORT 1 0.0000
381 ABDOMINAL PAIN UPPER 2 0.0000
382 PLATELET COUNT DECREASED 1 0.0000
383 CONSTIPATION 2 0.0000
384 MALAISE 4 0.0000
385 INFLUENZA 1 0.0000
386 THROMBOCYTOPENIA 1 0.0000
387 WEIGHT INCREASED 2 0.0000
388 ASTHMA 1 0.0000
389 RHEUMATOID ARTHRITIS 1 0.0000
390 INCORRECT DOSE ADMINISTERED 2 0.0000
391 DECREASED APPETITE 2 0.0000
392 CHILLS 1 0.0000
393 EMOTIONAL DISTRESS 1 0.0000
394 HEADACHE 5 0.0000
395 HYPERHIDROSIS 1 0.0000
396 RENAL FAILURE 1 0.0000
397 ARTHRALGIA 3 0.0000
398 COUGH 2 0.0000
399 PRODUCT DOSE OMISSION ISSUE 2 0.0000
400 HYPOAESTHESIA 1 0.0000
401 ACUTE KIDNEY INJURY 1 0.0000
402 HOSPITALISATION 1 0.0000
403 CONFUSIONAL STATE 1 0.0000
404 PNEUMONIA 2 0.0000
405 FALL 2 0.0000
406 MYALGIA 1 0.0000
407 PYREXIA 2 0.0000
408 COVID-19 1 0.0000
409 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
410 CHEST PAIN 1 0.0000
411 GAIT DISTURBANCE 1 0.0000
412 FATIGUE 4 0.0000
413 HYPERTENSION 1 0.0000
414 VOMITING 2 0.0000
415 INSOMNIA 1 0.0000
416 DEATH 2 0.0000
417 DYSPNOEA 1 0.0000